LSA
IMGN

Leonteq Securities AG’s Immunogen Inc IMGN Stock Holding History

Leonteq Securities AG’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,140
Closed -$10.6K – 1363
2022
Q4 		$10.6K Hold
2,140
– – ﹤0.01% 1044
2022
Q3 		$10.2K Hold
2,140
– – ﹤0.01% 1053
2022
Q2 		$9.63K Hold
2,140
– – ﹤0.01% 1089
2022
Q1 		$10.2K Hold
2,140
– – ﹤0.01% 1109
2021
Q4 		$15.9K Buy
+2,140
New +$13.3K ﹤0.01% 1095

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Leonteq Securities AG's IMGN Position: Q1 2023 in Review

Leonteq Securities AG sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 2,140 shares — an estimated $10.6K sold.

Leonteq Securities AG first reported a position in IMGN in Q4 2021 and held it in 5 quarters. The position peaked at $15.9K in Q4 2021. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

  • Leonteq Securities AG reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 2,140 Immunogen Inc shares in Q1 2023, an estimated $10.6K.
  • Leonteq Securities AG first reported a position in Immunogen Inc in Q4 2021 and held it in 5 quarters.
  • Leonteq Securities AG's Immunogen Inc position peaked at $15.9K in Q4 2021.
  • 190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on Leonteq Securities AG's 13F filing for Q1 2023, filed 11 Mar 2026.